-
Winter is Coming! —Events of the Chinese API Industry in 2017
Caicai
January 12, 2018
Winter is Coming! This line of the Game of Thrones well-known in the world may be used to best describe the current situation of the Chinese API industry.
-
End of the Era of API Approval Numbers! DMF Filing System Starting to be Implemented Formally
Caicai
December 27, 2017
Do you know how diligent this administration of CFDA is?
-
Perrigo Secures API Divestiture for $110M
contractpharm
November 22, 2017
Perrigo has completed its $ 110 million divestment of its API business in Israel
-
Sterling Expands API Capabilities
contractpharma
October 25, 2017
nvests ￡6 million to strengthen and expand its milling, micronization and solid form capabilities
-
Piramal Pharma Solutions invests US$55 million into API manufacturing facilities expansion
pharmaasia
October 20, 2017
Piramal Pharma's latest large scale expansion targets the capacity boosting of its API manufacturing sites across North America and Asia.
-
Piramal to expand in API manufacturing capabilities with $55m
pharmaceufical-technology
October 11, 2017
PPS, a subsidiary of Piramal Enterprises (PEL), is a major contract development and manufacturing organisation (CDMO).
-
Piramal Invests $55M to Expand API Mfg. Capabilities
contractpharma
October 10, 2017
Piramal Pharma Solutions (PPS), a contract development and manufacturing organization (CDMO) is investing?$55 million?across its sites in?North America?&?Asia, to expand its API manufacturing capabilities and capacities.
-
Clariant launches Amide/Amine-Free Anti-Static Concentrate for clean-room and API films
expressbpd
September 27, 2017
Clariant has launched a new amide/amine-free anti-static masterbatch concentrate for polyethylene films used in pharma production.
-
SK Capital to buy API business from Perrigo Company
pharmaceutical-technology
August 15, 2017
Private investment company SK Capital has signed a new definitive agreement to purchase Perrigo Company’s active pharmaceutical ingredients (API) business, Perrigo API.Perrigo API develops and produces generic APIs and finished dose forms (FDF).
-
Perrigo offloading its ingredient business to private equity investor for $110M
fiercepharma
August 11, 2017
Perrigo, which sold this API plant in India to Strides Shasun, now has a deal to sell its Israel API business to SK Capital for $110 million.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
